Average Co-Inventor Count = 4.10
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (23 from 2,405 patents)
2. Merck + Co., Inc. (22 from 4,770 patents)
3. Cortexyme, Inc. (6 from 9 patents)
4. Silverback Therapeutics, Inc. (4 from 6 patents)
5. Other (2 from 832,880 patents)
6. Sunesis Pharmaceuticals, Inc. (2 from 63 patents)
7. Zenith Epigenetics Corp. (1 from 24 patents)
8. Alectos Therapeutics Inc. (18 patents)
58 patents:
1. 11332464 - Inhibitors of lysine gingipain
2. 11053243 - Inhibitors of hepatitis C virus replication
3. 10906881 - Inhibitors of arginine gingipain
4. 10745377 - Piperidine or piperazine linked imidazole and triazole derivatives and methods of use
5. 10738062 - Chromane-substituted tetracyclic compounds and uses thereof for the treatment of viral diseases
6. 10676470 - Inhibitors of lysine gingipain
7. 10646494 - Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases
8. 10519131 - Benzazepine compounds, conjugates, and uses thereof
9. 10442790 - Benzazepine compounds, conjugates, and uses thereof
10. 10428045 - Benzazepine compounds, conjugates, and uses thereof
11. 10301301 - Inhibitors of lysine gingipain
12. 10292968 - Substituted heterocycles as bromodomain inhibitors
13. 10239862 - Benzazepine compounds, conjugates, and uses thereof
14. 9988375 - Inhibitors of lysine gingipain
15. 9981969 - Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug